Clinical Transplantation

Article	Citations
Early effects of first‐line treatment with anti‐interleukin‐6 receptor antibody tocilizumab for chronic active antibody‐mediated rejection in kidney transplantation	49
Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients	44
Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States	42
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications	38
Pig kidney xenotransplantation: Progress toward clinical trials	36
Pediatric transplantation in Europe during the COVID‐19 pandemic: Early impact on activity and healthcare	35
Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience	32
Hypothermic machine perfusion is superior to static cold storage in deceased donor kidney transplantation: A meta‐analysis	31
Organ donation and transplant: The Islamic perspective	30
Financial impact of delayed graft function in kidney transplantation	30
Incidence, risk factors, treatment, and consequences of antibody‐mediated kidney transplant rejection: A systematic review	30
Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐19	30
Convalescent plasma therapy: Helpful treatment of COVID‐19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications	30
Early United States experience with liver donation after circulatory determination of death using thoraco‐abdominal normothermic regional perfusion: A multi‐institutional observational study	27
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine	27
Does liver biopsy accurately measure fibrosis in Fontan‐associated liver disease? A comparison of liver biopsy pre–combined heart and liver transplant and liver explant post‐transplant	25
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expe	25
State‐of‐the‐art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database	25
A short overview on mycophenolic acid pharmacology and pharmacokinetics	24
Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United States	24
Attenuated early inflammatory response in solid organ recipients with COVID‐19	23
Treatment with convalescent plasma in solid organ transplant recipients with COVID‐19: Experience at large transplant center in New York City	23
Does machine perfusion improve immediate and short‐term outcomes by enhancing graft function and recipient recovery after liver transplantation? A systematic review of the literature, meta‐analysis an	23
Development of the living donation and kidney transplantation information made easy (KidneyTIME) educational animations	23
Viability testing of discarded livers with normothermic machine perfusion: Alleviating the organ shortage outweighs the cost	23

Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors	23
Enhanced recovery after surgery programs improve short‐term outcomes after liver transplantation–A systematic review and meta‐analysis	22
Impact of heart transplant allocation change on competing waitlist outcomes among listing strategies	22
Transplant outcomes using kidneys from high KDPI acute kidney injury donors	21
Protocolized exercise improves frailty parameters and lower extremity impairment: A promising prehabilitation strategy for kidney transplant candidates	20
Pre‐transplant short physical performance battery: Response to pre‐habilitation and relationship to pre‐ and early post–lung‐transplant outcomes	20
To kidney or not to kidney: Applying lessons learned from the simultaneous liver‐kidney transplant policy to simultaneous heart‐kidney transplantation	20
Global experience and perspective on anonymous nondirected live donation in living donor liver transplantation	19
Tocilizumab use in Kidney Transplant Patients with COVID‐19	19
Engraftment syndrome following hematopoietic stem cell transplant: A review of the literature	18
The shared epitope phenomenon—A potential impediment to virtual crossmatch accuracy	18
Using race to estimate glomerular filtration and its impact in kidney transplantation	18
The influence of ischemia and reperfusion time on outcome in heart transplantation	18
COVID‐19 in hospitalized liver transplant recipients: An early systematic review and meta‐analysis	18
Telehealth in outpatient management of kidney transplant recipients during COVID‐19 pandemic in New York	17
Prognostic value of the donor‐derived cell‐free DNA assay in acute renal rejection therapy: A prospective cohort study	17
Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment	17
Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come	17
Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea	17
Impact of pre‐transplant carbapenem‐resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes	16
Transversus abdominis plane (TAP) block for laparoscopic live donor nephrectomy: Continuous catheter infusion provides no additional analgesic benefit over single‐injection ropivacaine	16
Removal of the Black race coefficient from the estimated glomerular filtration equation improves transplant eligibility for Black patients at a single center	16
Perioperative fluid management and outcomes in adult deceased donor liver transplantation – A systematic review of the literature and expert panel recommendations	15
Abdominal wall complications after kidney transplantation: A clinical review	15
Utilization of direct‐acting oral anticoagulation in solid organ transplant patients: A national survey of institutional practices	15
Belatacept, kidney transplantation and COVID‐19: Successful management of the first reported case within the United Kingdom	15
Induction immunosuppression strategies and long‐term outcomes after heart transplantation	15
Gender differences in heart transplantation: Twenty‐five year trends in the nationwide Spanish heart transplant registry	14
Operational challenges in the COVID‐19 era: Asymptomatic infections and vaccination timing	14
What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations	14
Targeting the NLRP3 inflammasome to reduce warm ischemic injury in donation after circulatory death heart	14
The impact of the SARS‐CoV‐2 pandemic and COVID‐19 on lung transplantation in the UK: Lessons learned from the first wave	14
Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients	14
Describing barriers and facilitators for medication adherence and self‐management among kidney transplant recipients using the information‐motivation‐behavioral skills model	14
The type of SARS‐CoV‐2 vaccine influences serological response in kidney transplant recipients	14
Lung transplantation for the treatment of irreversible acute respiratory distress syndrome	14
Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID‐19)	14
Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system	14
Transplantation of viral‐positive hepatitis C‐positive kidneys into uninfected recipients offers an opportunity to increase organ access	14
Outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis	14
Donor‐derived cell‐free DNA is associated with cardiac allograft vasculopathy	14
A proposed strategy for management of immunosuppression in heart transplant patients with COVID‐19	13
Sex differences in eligibility for advanced heart failure therapies	13
Genome‐wide association study for time to failure of kidney transplants from African American deceased donors	13
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De‐novo heart transplant recipients: Design of the randomized controlled EVOLVD trial	13
Clinical judgment versus lung allocation score in predicting lung transplant waitlist mortality	13
Pediatric lung transplantation as standard of care	13
Heart transplant recipients with confirmed 2019 novel coronavirus infection: The Detroit experience	13
Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry	13
Renal transplantation during the SARS‐CoV‐2 pandemic in the UK: Experience from a large‐volume center	13

Wait expectations: The impact of delisting as an outcome from the kidney transplant waitlist	13
Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations	13
Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality	13
Normothermic with or without hypothermic oxygenated perfusion for DCD before liver transplantation: European multicentric experience	13
A Step toward Standardization: Results of two National Surveys of Best Practices in Donation after Circulatory Death Liver Recovery and Recommendations from The American Society of Transplant Surgeons	12
Immunosuppression practices during the COVID‐19 pandemic: A multinational survey study of transplant programs	12
A single‐center long‐term experience with marginal donor utilization for heart transplantation	12
Disparities in DCD organ procurement policy from a national OPO survey: A call for standardization	12
eHealth literacy and web‐based patient portal usage among kidney and liver transplant recipients	12
Mobile health technology to improve emergent frailty after lung transplantation	12
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump	12
Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction	12
Exploring the motives of Israeli Jews who were living kidney donors to strangers	12
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia	12
Association of race and gender with primary caregiver relationships and eligibility for advanced heart failure therapies	12
Long‐term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism	12
Which preoperative assessment modalities best identify patients who are suitable for enhanced recovery after liver transplantation? A systematic review of the literature and expert panel recommendatio	11
Exercise interventions in solid organ transplant candidates: A systematic review	11
Kidney transplantation using lymphocyte depleting induction and standard maintenance immunosuppression at the height of the SARS‐CoV‐2 pandemic in New York City: A single‐center experience	11
COVID‐19 in heart transplant recipients during February–August 2020: A systematic review	11
SARS‐CoV‐2 infection increases tacrolimus concentrations in solid‐organ transplant recipients	11
Hyperammonemia syndrome associated with Ureaplasma spp. Infections in immunocompromised patients and transplant recipients: A systematic review and meta‐analysis	11
Kidney allograft rejection: Diagnosis and treatment practices in USA‐ A UNOS survey	11
Sodium‐glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation	11
Nitazoxanide treatment for norovirus infection in solid organ transplant recipients	11
A retrospective multi‐center experience of renal transplants from India during COVID‐19 pandemic	11
Model for early allograft function is predictive of early graft loss in donation after circulatory death liver transplantation	11
Donor thyroid hormone therapy is associated with an increased risk of graft dysfunction after heart transplantation	11
Acute kidney injury post‐heart transplant: An analysis of peri‐operative risk factors	11
CD4+ T cell lymphopenia predicts mortality from Pneumocystis pneumonia in kidney transplant patients	11
What is the optimal anesthetic monitoring regarding immediate and short‐term outcomes after liver transplantation?—A systematic review of the literature and expert panel recommendations	11
Early changes in IL‐21, IL‐22, CCL2, and CCL4 serum cytokines after outpatient autologous transplantation for multiple sclerosis: A proof of concept study	10
Longitudinal variance of Donor‐Derived Cell‐Free DNA (dd‐cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables	10
National survey of physicians’ perspectives on pharmacogenetic testing in solid organ transplantation	10
Magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation	10
Polygenic risk score of non‐melanoma skin cancer predicts post‐transplant skin cancer across multiple organ types	10
Early persistent hyperparathyroidism post‐renal transplantation as a predictor of worse graft function and mortality after transplantation	10
Histopathologic findings on indication renal allograft biopsies after recovery from acute COVID‐19	10
Impact of the duration of normothermic regional perfusion on the results of liver transplant from controlled circulatory death donors: A retrospective, multicentric study	10
Variations in deceased donor kidney procurement biopsy practice patterns: A survey of U.S. organ procurement organizations	10
Left‐digit bias and deceased donor kidney utilization	10
Predicting harmful alcohol relapse after liver transplant: The HALT score	10
Strict selection criteria in uncontrolled donation after circulatory death provide excellent long‐term kidney graft survival	10
Decreased frequency of transplantation and lower post‐transplant survival free of re‐transplantation in LVAD patients with the new heart transplant allocation system	10
Post‐transplant survival in adult congenital heart disease patients as compared to dilated and ischemic cardiomyopathy patients; an analysis of the thoracic ISHLT registry	10
Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature	10
Impact of donor smoking history on post heart transplant outcomes: A propensity‐matched analysis of ISHLT registry	10
The changing landscape of pediatric lung transplantation	10
Care of international living kidney donor candidates in the United States: A survey of contemporary experience, practice, and challenges	10
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin	10
Adult liver transplant anesthesiology practice patterns and resource utilization in the United States: Survey results from the society for the advancement of transplant anesthesia	10
Transplantation of kidneys after normothermic perfusion: A single center experience	10
Risk of COVID‐19 in young kidney transplant recipients. Results from a single‐center observational study	9
ProtekDuo as a bridge to lung transplant and heart‐lung transplant	9
The role of early extubation on short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert recommendations	9
Associations of perceived information adequacy and knowledge with pursuit of live donor kidney transplants and living donor inquiries among African American transplant candidates	9
The role of prehabilitation on short‐term outcomes after liver transplantation: A review of the literature and expert panel recommendations	9
Quick preparation of ABO‐incompatible living donor liver transplantation for acute liver failure	9
Management and tolerability of glecaprevir‐pibrentasvir pharmacotherapy in hepatitis C viremic heart and lung transplant recipients	9
Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct‐acting antiviral initiation	9
Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant‐related risk factors and current state of prophylaxis	9
Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases	9
Increased frequency of heart transplantation, shortened waitlist time and preserved post‐transplant survival in adults with congenital heart disease, on the new heart transplant allocation system	9
Blood transfusion of the donor is associated with stage 3 primary graft dysfunction after lung transplantation	9
The role of preoperative optimization of the nutritional status on the improvement of short‐term outcomes after liver transplantation? A review of the literature and expert panel recommendations	9
Anesthetic management of lung transplantation: Results from a multicenter, cross‐sectional survey by the society for advancement of transplant anesthesia	9
Incidence and risk factors of primary non‐function after liver transplantation using grafts from uncontrolled donors after circulatory death	9
Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort?	9
Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol‐related liver disease	9
Anti‐Hla donor‐specific antibody monitoring in pancreas transplantation: Role of protocol biopsies	9
The COVID‐19 pandemic: A community approach	9
Meta‐analysis and systematic review: Prevalence, graft failure, mortality, and post‐operative thrombosis in liver transplant recipients with pre‐operative portal vein thrombosis	9
The role of acute in‐patient rehabilitation on short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations	8
Podocyte density is reduced in kidney allografts with high‐risk APOL1 genotypes at transplantation	8
Clinical outcome of kidney transplantation after bariatric surgery: A single‐center, retrospective cohort study	8
Takotsubo syndrome after liver transplantation: An association with intraoperatively administered epinephrine and fentanyl	8
Long‐term outcomes in kidney transplant recipients with end‐stage kidney disease due to anti‐glomerular basement membrane disease	8
Acute and chronic kidney disease after pediatric liver transplantation: An underestimated problem	8
Impact of COVID‐19 pandemic on the size of US transplant waiting lists	8
Outcomes of kidney donors with pre‐ and post‐donation kidney stones	8

Physician and patient acceptance of policies to reduce kidney discard	8
Ethical considerations regarding COVID‐19 vaccination for transplant candidates and recipients	8
Molecular assessment of antibody‐mediated rejection in human pancreas allograft biopsies	8
Optimal management of perioperative analgesia regarding immediate and short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert panel recommendations	8
Lung allocation for transplant: The European perspective	8
Impact of warm ischemia time on outcomes for kidneys donated after cardiac death Post‐KAS	8
Post‐transplant inotrope score is associated with clinical outcomes after adult heart transplantation	8
Impact of diabetes mellitus on clinical outcomes after heart transplantation	8
Which cava anastomotic techniques are optimal regarding immediate and short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations	8
Textbook surgical outcome in lung transplantation: Analysis of a US national registry	8
Alternatives to immediate release tacrolimus in solid organ transplant recipients: When the gold standard is in short supply	8
Public education materials about Vascular Composite Allotransplantation and donation in the United States: Current scope and limitations	8
Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome	8
Implementation of a mobile team to provide normothermic regional perfusion in controlled donation after circulatory death: Pilot study and first results	8
Optimal anesthetic conduct regarding immediate and short‐term outcomes after liver transplantation – Systematic review of the literature and expert panel recommendations	8
Pancreas transplantation would be easy if the recipients were not diabetic: A practical guide to post‐operative management of diabetic complications in pancreas transplant recipients	8
Impact of induction therapy on outcomes after heart transplantation	8
Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy	8
The role of graft to recipient weight ratio on enhanced recovery of the recipient after living donor liver transplantation – A systematic review of the literature and expert panel recommendations	8
Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study	8
Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant	8
Survival and renal function after liver transplantation alone in patients meeting the new United Network for Organ Sharing simultaneous liver‐kidney criteria	8
Long‐term outcomes of Roux‐en‐Y gastric bypass or sleeve gastrectomy in patients with cirrhosis; before, during or after liver transplantation: A single center's experience	8
Gastric peroral endoscopic myotomy (GPOEM) for severe gastroparesis after lung transplantation: A promising minimally invasive option	7
Lung transplantation outcomes after crossing low‐level donor specific antibodies without planned augmented immunosuppression	7
Conversion to belatacept within 1‐year of renal transplantation in a diverse cohort including patients with donor‐specific antibodies	7
Impact of body mass index and recipient age on baseline donor‐derived cell free DNA (dd‐cfDNA) in kidney transplant recipients	7
Implementation of patient‐reported outcome measures in a heart transplant recipient registry: First step toward a patient‐centered approach	7
Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system	7
An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients	7
Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: Meta‐analysis	7
Incidence, risk factors, and clinical outcomes associated with Epstein‐Barr virus‐DNAemia and Epstein‐Barr virus‐associated disease in patients after haploidentical allogeneic stem cell transplantatio	7
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients	7
Liver transplantation for combined hepatocellular‐cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis	7
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation	7
Sex and gender disparity in kidney transplantation: Historical and future perspectives	7
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization	7
Six‐month risk of Pneumocystis pneumonia following acute cellular rejection: A case‐control study in solid organ transplant recipients	7
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and	7
Organ transplant and Covid‐19 vaccination: Considering the ethics of denying transplant to unvaccinated patients	7
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients	7
The impact of depression on heart transplant outcomes: A retrospective single‐center cohort study	7
Geographic disparities in heart transplantation persist under the new allocation policy	7
Outcomes among CMV‐mismatched and highly sensitized kidney transplants recipients who develop neutropenia	7
Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario	7
Intermediate‐term outcomes of heart transplantation for cardiac amyloidosis in the current era	7
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States	7
Torquetenovirus viral load is associated with anti‐spike antibody response in SARS‐CoV‐2 mRNA BNT162b2 vaccinated kidney transplant patients	7
Multimodal opioid‐sparing pain management after lung transplantation and the impact of liposomal bupivacaine intercostal nerve block	7
Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy	7
Intravascular ultrasound–guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients	7
A comparison of cardiopulmonary bypass versus extracorporeal membrane oxygenation: Does intraoperative circulatory support strategy affect outcomes in pediatric lung transplantation?	7
Volumetrics and fit assessments for donor to recipient size matching in pediatric heart transplantation: Is it time for a new paradigm?	7
Cognitive impairment burden in older and younger adults across the kidney transplant care continuum	7
Adoption of a novel smart mobile‐health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot	7
ABO‐incompatible living kidney transplantation	7
Evaluating resilience as a predictor of outcomes in lung transplant candidates	7
Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results	7
Recipient age and outcomes following simultaneous pancreas‐kidney transplantation in the new millennium: Single‐center experience and review of the literature	7
The impact of marijuana use on liver transplant recipients: A 900 patient single center experience	7
Predictive score for immediate extubation after liver transplantation	7
Effectiveness and safety of glucagon‐like peptide‐1 receptor agonist in a cohort of kidney transplant recipients	7
The Molecular Microscope (MMDXR) interpretation of thoracic and abdominal allograft biopsies: Putting things in perspective for the clinician	7
Treatment of borderline infiltrates with minimal inflammation in kidney transplant recipients has no effect on allograft or patient outcomes	7
Racial disparities in living donor kidney transplantation in the United States	7
NSAID prescriptions in kidney transplant recipients	7
Outcomes of living‐donor liver transplantation for acute‐on‐chronic liver failure based on newly proposed criteria in Japan	7
Plasma mycophenolic acid concentration and the clinical outcome after lung transplantation	7
Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound	7
Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors	7
The effects of donor‐specific antibody characteristics on cardiac allograft vasculopathy	7
Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression	6
Combination of pancreas volume and HbA1c level predicts islet yield in patients undergoing total pancreatectomy and islet autotransplantation	6
Race does not predict pancreas graft failure after pancreas transplantation in the modern era	6
Incidence, risk factors, and long‐term outcomes associated with antibody‐mediated rejection — The long‐term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study	6
User‐centered design features for digital health applications to support physical activity behaviors in solid organ transplant recipients: A qualitative study	6
“Early” and “Late” Hospital readmissions in the first year after kidney transplant at a single center	6
Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation	6
Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization	6
Post‐transplant lymphoproliferative disorder with cutaneous involvement: A series of four cases	6
COVID‐19 in heart transplant recipients—A seroprevalence survey	6
Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States	6
Video education to facilitate patient outreach about living kidney donation: A proof of concept	6
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience	6
Use of Continuous Glucose Monitoring for evaluation of hypoglycemia pre‐ and post‐operatively for patients undergoing Total Pancreatectomy with Autologous Islet Cell Transplant	6
Marijuana use among adult liver transplant candidates and recipients	6
Can direct oral anticoagulants be used in kidney transplant recipients?	6
Role of a cardio‐renal multi‐disciplinary team meeting in managing cardiovascular risk in patients on kidney transplant waitlists	6
The efficacy of interleukin‐1 antagonist drugs in combination with colchicine in patients with FMF‐AA with colchicine resistance after kidney transplantation: A study with histopathologic evidence	6
Successful outcomes with transplanting kidneys from deceased donors with acute kidney injuryon temporary renal replacement therapy	6
Comparing outcomes in right versus left kidney transplantation: A systematic review and meta‐analysis	6
Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients	6
Predictive value of chart‐based frailty evaluation for lung transplant candidates	6
Utilizing multimodal analgesia to evaluate postoperative analgesic requirements in kidney transplant recipients	6
COVID‐19 test result reporting for deceased donors: Emergent policies, logistical challenges, and future directions	6